Rakuten Medical

Is a global biotechnology company developing precision cell targeting investigational therapies on its illuminox tm platform which in pre clinical studies have shown to.

Rakuten medical. Use one of the options below to contact us. Rakuten medical uses cetuximab in an intermediate form as the antibody component in its product candidate asp 1929 an investigational antibody dye conjugate being. Rakuten medical receives conditional early approval designation from japanese health ministry for its lead drug asp 1929 to treat recurrent head neck cancer. Rakuten medical announced they have entered a multi year deal with merck kgaa darmstadt germany under which merck kgaa darmstadt germany will provide cetuximab to rakuten medical for its asp 1929 program.

Asp 1929 specifically targets the epidermal growth factor receptor egfr. Is a global biotechnology company developing precision cell targeting investigational therapies on its illuminox technology platform which in pre clinical studies have been shown to induce rapid and selective cell killing and tumor necrosis. Asp 1929 is an antibody dye conjugate comprised of the antibody cetuximab and irdye 700dx a light activatable dye. Rakuten medical s first investigational drug based on the illuminox platform is asp 1929.

Is a global biotechnology company developing precision cell targeting investigational therapies on its illuminox technology platform which in pre clinical studies have been shown to induce rapid and selective cell killing and tumor necrosis rakuten medical is committed to its mission to conquer cancer and aims to realize a society where cancer patients can lead. Medical information inquiry form email. Thank you for your interest in rakuten medical. Rakuten medical a global biotechnology company developing precision cell targeting investigational therapies on its illuminox technology platform established a strategic cancer research alliance network the illuminox alliance institutes iai in order to advance the development of new cancer therapies.